Martin Pfister – Startup Investor Profile

Dr. Martin Pfister was a Principal and an expert for venture capital and investments in Life Science & Chemie startups at HTGF. His unfortunate passing in October 2023 marked the end of his impactful career. During his tenure, he focused on investments in Life Science & Chemie startups and contributed significantly to the growth of the sector. One of the notable successes under his guidance was the acquisition of the biosensor company lino Biotech by Miltenyi Biotec, showcasing his strategic acumen in investment decisions. His legacy includes a strong track record of successful investments and a profound impact on the startups he supported. His partnership and collaboration style emphasized fostering meaningful relationships with portfolio companies to drive mutual success.

Location:

Country: Switzerland

Investment Regions: EU

Investment Stages: pre-seed, seed

Website: https://www.htgf.de/en/team/dr-martin-pfister-2/

AI Reasoning: I found evidence that Dr. Martin Pfister was involved in the HTGF exit of lino Biotech, which was acquired by Miltenyi Biotec on February 22, 2023 (reported by HTGF on March 16, 2023). Given today’s date, the most recent known investment-related activity tied to him is this acquisition date. The time since that activity is less than 6 months? Wait: need to calculate precisely. From Feb 22, 2023 to Nov 1, 2025 is over 2 years, so more than 12 months. Therefore classification should be based on time since last known investment: that is greater than 12 months, so tag ‘low-active’. The startup mentioned in sources: lino Biotech. However, the final tag must be a single value. After verifying dates, assign ‘low-active’.

Low Activity – Only known angel investments more than 12 months ago.

Active – Known angel investments between the last 12 and 6 months.

Very Active – Known angel investments in the last 6 months.